NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from SRY Labs? Mail in a sample (US only) and let us test it.

Test my supply
+4 more ↓
88%
Finnrick rating
#10 of 419 Retatrutide vendors
32 of 35 classifiable tests passed
natural 91% · customers 3.8★ (16)
methodology · Purity focus
Finnrick analysis · Retatrutide

A January identity failure and an October 99.2% purity miss keep SRY Labs' Retatrutide record from being clean despite mostly strong purity results. Batch labeling is uneven, so newer COAs deserve closer reading.

methodology →
vendor intelligence report
Vendor Intelligence Report: SRY Labs

Corporate records lead to a real Shanghai Senria entity, but the live SRY storefront’s seller and UBO do not resolve from the legal notice, domains or wallet trail. DNS, mirror domains and checkout code expose a rotating web cluster and no-KYC payment path.

38 pages7 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.34
92%
36
2
Retatrutideselected
$0.83
88%
35
3
Ipamorelin
$0.70
74%
4
4
GHK-Cu
-
67%
9
5
Semaglutide
$0.55
64%
4
6
PT-141
$0.60
59%
2
7
Cagrilintide
$1.20
49%
8
8
BPC-157
$0.50
48%
8
10
TB-500
$1.15
39%
10
11
Tesamorelin
-
35%
12
12
CJC-1295
$2.60
33%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%20 Apr 2025: 56%3 Jul 2025: 61%16 Jul 2025: 62%24 Jul 2025: 65%4 Aug 2025: 68%4 Aug 2025: 70%11 Aug 2025: 73%4 Sep 2025: 77%4 Sep 2025: 78%4 Sep 2025: 80%30 Sep 2025: 82%3 Oct 2025: 84%3 Oct 2025: 84%3 Oct 2025: 85%5 Oct 2025: 87%5 Oct 2025: 88%5 Oct 2025: 88%5 Oct 2025: 89%6 Oct 2025: 89%9 Oct 2025: 90%17 Oct 2025: 91%23 Oct 2025: 91%30 Oct 2025: 91%25 Nov 2025: 92%29 Jan 2026: 88%15 Feb 2026: 89%20 Feb 2026: 90%2 Mar 2026: 90%19 Mar 2026: 90%25 Mar 2026: 91%8 Jun 2026: 91%24 Sep 2026: 91%5 Oct 2026: 88%20 Oct 2026: 88%20 Oct 2026: 88%15 Nov 2026: current 88%56%92%88%Apr 25Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from SRY Labs? Mail in a sample (US only) and let us test it.

Test my supply
SRY Labs Retatrutide test history
COA-backed lab tests
1-10 of 35

About SRY Labs test results from Finnrick

SRY Labs is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 12 peptides and 136 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible SRY Labs peptides in this dataset are Tirzepatide (36 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 136 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Retatrutide from SRY Labs? Mail in a sample (US only) and let us test it.

Test my supply